SEARCH RESULTS FOR: "Tag: ACRX"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(3)
2017(3)
2015(3)
CATEGORIES
Analyst Update(2)
Buzz Stocks(2)
General(1)
Intraday Option Activity(1)
Opening View(1)
Stock Market News(1)
Stocks On the Move(3)

10/15/2018 1:15 PM
The shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) surged almost 37% last week -- their biggest one-week gain since September 2017 -- after a Food and Drug Administration (FDA) panel deemed the c...
10/10/2018 2:00 PM
Stocks are getting hammered today, with the tech sector leading the pullback. Three healthcare names making big moves are Myriad Genetics, Inc. (NASDAQ:MYGN), Ra Pharmaceuticals, Inc. (NASDAQ:RARX)...
6/12/2018 10:06 AM
Pain specialist AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is up 3.4% at $3.78 in early trading, after Cantor Fitzgerald initiated coverage on the stock with an "overweight" rating and price target of ...
10/12/2017 10:05 AM
U.S. stocks are trading slightly lower this morning, as third-quarter earnings season commences. Among the stocks making moves this morning are banking institution and blue-chip powerhouse JPMorgan ...
10/12/2017 9:12 AM
Dow Jones Industrial Average (DJIA) futures are slightly lower ahead of the bell, following another record close yesterday, as financial stocks kick off third-quarter earnings season. JPMorgan Chase...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center